Chandrassegar Saravanan (Chandra Saravanan)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Topics

Optical Coherence Tomography

Immune Response

Vascular Endothelial Growth Factor

Top Venues

Science translational medicine

Toxicologic pathology

This page only lists publications with an associated author ORCID identifier.

Publications

Anette C Karle, Matthias B Wrobel, Stephan Koepke, Michael Gutknecht, Sascha Gottlieb, Brigitte Christen, Tina Rubic-Schneider, Ingrid Pruimboom-Brees, Xavier Charles Leber, Meike Scharenberg, Benjamin Maciejewski, Oliver C Turner, Chandrassegar Saravanan, François Huet, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Jeffrey D Kearns, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events. Science translational medicine 15 (681) (2023)
Anette C Karle, Matthias B Wrobel, Stephan Koepke, Michael Gutknecht, Sascha Gottlieb, Brigitte Christen, Tina Rubic-Schneider, Ingrid Pruimboom-Brees, Xavier Charles Leber, Meike Scharenberg, Benjamin Maciejewski, Oliver C Turner, Chandrassegar Saravanan, François Huet, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Jeffrey D Kearns, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events. Science translational medicine 15 (681) (2023)
Anette C Karle, Matthias B Wrobel, Stephan Koepke, Michael Gutknecht, Sascha Gottlieb, Brigitte Christen, Tina Rubic-Schneider, Ingrid Pruimboom-Brees, Xavier Charles Leber, Meike Scharenberg, Benjamin Maciejewski, Oliver C Turner, Chandrassegar Saravanan, François Huet, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Jeffrey D Kearns, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events. Science translational medicine 15 (681) (2023)
Xavier Palazzi, Erio Barale, Bhupinder Bawa, Jonathan Carter, Kyathanahalli S Janardhan, Heike Antje Marxfeld, Abraham Nyska, Chandrassegar Saravanan, Dirk Schaudien, Vanessa L Schumacher, Robert H Spaet, Simone Tangermann, Oliver C Turner, Enrico Vezzali
Results of the European Society of Toxicologic Pathology Survey on the Use of Artificial Intelligence in Toxicologic Pathology. Toxicologic pathology 51 (4) (2023)
Josep M Monné Rodríguez, Anna-Lena Frisk, Robert Kreutzer, Thomas Lemarchand, Stephane Lezmi, Chandrassegar Saravanan, Birgit Stierstorfer, Céline Thuilliez, Enrico Vezzali, Grazyna Wieczorek, Seong-Wook Yun, Dirk Schaudien
European Society of Toxicologic Pathology (Pathology 2.0 Molecular Pathology Special Interest Group): Review of In Situ Hybridization Techniques for Drug Research and Development. Toxicologic pathology (2023)
Anette C Karle, Matthias B Wrobel, Stephan Koepke, Michael Gutknecht, Sascha Gottlieb, Brigitte Christen, Tina Rubic-Schneider, Ingrid Pruimboom-Brees, Xavier Charles Leber, Meike Scharenberg, Benjamin Maciejewski, Oliver C Turner, Chandrassegar Saravanan, François Huet, Amanda Littlewood-Evans, Andreas Clemens, Cynthia L Grosskreutz, Jeffrey D Kearns, Pawan Mehan, Robert L Schmouder, Vito Sasseville, Dominique Brees
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events. Science translational medicine 15 (681) (2023)